Daily non-political popular news in brief.
Anxiety hikes risk of heart attack, death
05-14-2007 · EurekAlert!New research shows that highly anxious patients with heart disease face nearly double the risk of heart attack or death when compared to those with a more serene outlook on life. Patients whose anxiety intensified over time were in greatest peril, while those who started out highly anxious but later found inner calm markedly reduced their risk. The research appears in the May 22, 2007, issue of the Journal of the American College of Cardiology.
Read more »
Keywords: anxiety, hikes, risk, heart, attack, death, hike
« Previous | Next »
Similar news on "Anxiety hikes risk of heart attack, death":
- Here's something new to worry about: Anxiety hikes heart attack risk
01-07-2008 · EurekAlert!
We all know that people with a type A personality and an off-the-charts hostility level may be courting a heart attack. But this might come as a surprise: New research shows that their nervous, socially withdrawn neighbors also have reason to worry. The research, published in the Jan. 15, 2008, issue of the Journal of the American College of Cardiology, shows that longstanding anxiety markedly increases the risk of heart attack, even when other common risk factors are taken into account.
Similar news · Read more »
- Use of diabetes medication by older adults linked with increased risk of heart problems, death
12-11-2007 · EurekAlert!
Older patients treated with the diabetes medications known as thiazolidinediones (which include rosiglitazone) had a significantly increased risk of heart attack, congestive heart failure and death, compared with the use of other hypoglycemic drugs, according to a study in the Dec. 12 issue of JAMA. The authors suggest that these results provide further evidence that this class of medication may cause more harm than good.
Similar news · Read more »
- New blood thinner may work without bleeding risk
03-26-2007 · EurekAlert!
Clinical trial of new blood thinner shows promise of significantly reducing the risk of heart attack and death with no statistical increase in major and minor bleeding events.
Similar news · Read more »
- Patients at risk of adverse events within 3 months after stopping certain ACS therapy
02-05-2008 · EurekAlert!
Patients who receive the anti-platelet medication clopidogrel following an acute coronary syndrome (such as heart attack) appear to be at greater risk of a heart attack or death in the first 90 days after stopping clopidogrel treatment, according to a study in the Feb. 6 issue of JAMA.
Similar news · Read more »
- Drug does not reduce risk of death for heart attack patients with refractory shock
03-26-2007 · EurekAlert!
The medication tilarginine, a drug that was believed could be beneficial for patients who develop cardiogenic shock (low blood pressure due to impaired cardiac function) after a heart attack, did not reduce the risk of death up to six months after a heart attack, according to a JAMA study published online March 26. The study is being released early to coincide with its presentation at the American College of Cardiology's annual conference.
Similar news · Read more »
- Long-term use of diabetes drug increases heart attack risk by more than 40 percent
09-11-2007 · EurekAlert!
An analysis of four studies involving more than 14,000 patients found that long-term use of the diabetes drug rosiglitazone (Avandia) increased the risk of heart attack by 42 percent and doubled the risk of heart failure, according to a new report from researchers at Wake Forest University School of Medicine and colleagues. There was no effect on death from cardiovascular causes.
Similar news · Read more »
- Sleep apnea increases risk of heart attack or death by 30 percent
05-20-2007 · EurekAlert!
The nighttime breathing disorder known as obstructive sleep apnea increases a person's risk of having a heart attack or dying by 30 percent over a period of four to five years, according to a study presented at the American Thoracic Society 2007 International Conference, on Monday, May 21.
Similar news · Read more »
- Glycemic control medication appears to have favorable effect regarding risk of cardiovascular events
09-11-2007 · EurekAlert!
A meta-analysis of previous research suggests that use of pioglitazone -- a glycemic control medication for patients with type 2 diabetes -- significantly reduces the risk of heart attack, stroke and death, but increases the risk for serious heart failure, according to an article in the Sept. 12 issue of JAMA.
Similar news · Read more »
- Asian women at risk for arterial defect
02-07-2008 · EurekAlert!
A seemingly random arterial abnormality that can cause heart attack and sudden death in adults with no previous symptoms may not be so random after all.
Similar news · Read more »
- Anti-anginal drug safe but not effective in reducing major cardiac events in ACS patients
04-24-2007 · EurekAlert!
The anti-anginal medication ranolazine was shown to be safe in regard to certain outcomes but did not reduce the risk of major cardiovascular events such as death, heart attack or recurrent ischemia following acute coronary syndromes, according to a study in the April 25 issue of JAMA.
Similar news · Read more »